October 5, 2021 CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19
October 5, 2021 Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19
October 3, 2021 View Now: IBD Biomarker Regulatory Science Webinar Wednesday, March 10, 10 a.m. ET The 3TR IMI project consortium and Critical Path Institute invite you to participate in the IBD
September 29, 2021 Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review C-Path's Huntington's Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based...
September 24, 2021 Critical Path for Parkinson’s Consortium 3DT Initiative: Recommendations for involving people with Parkinson’s in clinical studies using digital health tools Recommendations for involving people with Parkinson’s in clinical studies using digital health tools
September 14, 2021 Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
September 14, 2021 VIEW NOW | 2021 RDCA-DAP® Workshop The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerat
August 25, 2021 WEBINAR | Alternative Solutions in Safety Assessment When: August 25, 2021, 10 – 11:30 a.m. ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi
August 17, 2021 View Now | C-Path Neuroscience Program Webinar – NfL in Neurodegenerative Diseases C-Path’s Neuroscience Program hosted its first webinar on August 17, 2021. This webinar brought together more than 330 members,
